Operating
Change in Other Liabilities
Vertex Pharmaceuticals Change in Other Liabilities increased by 26.1% to $105.80M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Change in Other Liabilities shows an upward trend with a 106.8% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
A decrease indicates the company is paying down its miscellaneous obligations, which is a use of cash.
Detailed definition
This reflects the net change in various short-term and long-term obligations, such as deferred revenue, accrued expenses...
Peer comparison
For companies with large subscription or service businesses, changes in deferred revenue (a component here) are a key indicator of future growth.
Metric ID:
cf_change_in_other_liabilitiesHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$54.25M | -$21.36M | $84.13M | $15.70M | -$47.40M | -$9.00M | $539.60M | $89.40M | $28.40M | $35.60M | $55.50M | $167.60M | -$256.60M | $134.10M | $22.00M | -$63.20M | $83.90M | $105.80M |
| QoQ Change | — | +60.6% | +493.9% | -81.3% | -401.9% | +81.0% | >999% | -83.4% | -68.2% | +25.4% | +55.9% | +202.0% | -253.1% | +152.3% | -83.6% | -387.3% | +232.8% | +26.1% |
| YoY Change | — | — | — | — | +12.6% | +57.9% | +541.4% | +469.4% | +159.9% | +495.6% | -89.7% | +87.5% | <-999% | +276.7% | -86.9% | +75.4% | -37.4% | — |
Range-$256.60M – $539.60M
CAGR+17.0%
Avg YoY Growth+73.7%
Median YoY Growth+75.4%
Current Streak2 quarters growth
Change in Other Liabilities at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's change in other liabilities?
- Vertex Pharmaceuticals (VRTX) reported change in other liabilities of $105.80M in Q4 2025.
- What is the long-term trend for Vertex Pharmaceuticals's change in other liabilities?
- Over 3 years (2021 to 2025), Vertex Pharmaceuticals's change in other liabilities has grown at a 106.8% compound annual growth rate (CAGR), from $16.80M to $148.50M.
- What does change in other liabilities mean?
- The change in miscellaneous debts and obligations the company owes to others.